martes, 8 de diciembre de 2020

Best Practices in Developing Proprietary Names for Human Prescription Drug Products; Guidance for Industry | FDA

Best Practices in Developing Proprietary Names for Human Prescription Drug Products; Guidance for Industry | FDA

No hay comentarios:

Publicar un comentario